SUE KIM: Open Payments
NPI 1669130142 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 39 payments from 22 companies in 2025. Trend: 2023 $421 · 2024 $746 · 2025 $985
Food & beverage: $956Education: $29
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $158 |
| Amgen Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| Merck Sharp & Dohme LLC | 2 | $66 |
| SOBI, INC | 2 | $60 |
| Celgene Corporation | 2 | $59 |
| Janssen Biotech, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Blueprint Medicines Corporation | 1 | $37 |
| Astellas Pharma US Inc | 1 | $30 |
Products named: EVENITY, KEYTRUDA, REBLOZYL, TIVDAK, ELREXFIO, AYVAKIT, Vonjo, Vyloy.
Industry payments across GA — which companies pay providers there.
